Jazz Pharmaceuticals Gestione
Gestione criteri di controllo 3/4
Jazz Pharmaceuticals Il CEO è Bruce Cozadd, nominato in Jan2003, e ha un mandato di 21.83 anni. la retribuzione annua totale è $ 15.34M, composta da 7.8% di stipendio e 92.2% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.51% delle azioni della società, per un valore di $ 34.76M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.2 anni e 11.5 anni.
Informazioni chiave
Bruce Cozadd
Amministratore delegato
US$15.3m
Compenso totale
| Percentuale dello stipendio del CEO | 7.8% |
| Mandato del CEO | 21.8yrs |
| Proprietà del CEO | 0.5% |
| Durata media del management | 5.2yrs |
| Durata media del Consiglio di amministrazione | 11.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Does Jazz Pharmaceuticals (NASDAQ:JAZZ) Have A Healthy Balance Sheet?
Oct 22
Jazz Pharmaceuticals: Unexpected Wins Improve The Long-Term Outlook
Oct 16Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Looks Inexpensive But Perhaps Not Attractive Enough
Sep 25Jazz Pharmaceuticals: Zanidatamab Is A Potential Growth Catalyst
Sep 19Here's Why Shareholders Should Examine Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) CEO Compensation Package More Closely
Jul 18Here's Why Jazz Pharmaceuticals (NASDAQ:JAZZ) Has A Meaningful Debt Burden
Jun 23Jazz Pharmaceuticals: Pipeline Setback While Business Transition Continues
Jun 21Jazz Pharmaceuticals: Targeting The Low-Hanging Fruit In Oncology Might Pay Off
Apr 15Insufficient Growth At Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Hampers Share Price
Apr 02Is Jazz Pharmaceuticals (NASDAQ:JAZZ) A Risky Investment?
Feb 18Updated View On Jazz Pharmaceuticals' 2025 Goals
Jan 29Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) Price Is Right But Growth Is Lacking
Dec 26Jazz Pharmaceuticals (NASDAQ:JAZZ) Seems To Use Debt Quite Sensibly
Oct 31Does Jazz Pharmaceuticals (NASDAQ:JAZZ) Have A Healthy Balance Sheet?
Jul 12We Think Jazz Pharmaceuticals (NASDAQ:JAZZ) Can Stay On Top Of Its Debt
Apr 12Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$395m |
| Mar 31 2024 | n/a | n/a | US$331m |
| Dec 31 2023 | US$15m | US$1m | US$415m |
| Sep 30 2023 | n/a | n/a | US$80m |
| Jun 30 2023 | n/a | n/a | -US$87m |
| Mar 31 2023 | n/a | n/a | -US$156m |
| Dec 31 2022 | US$17m | US$1m | -US$224m |
| Sep 30 2022 | n/a | n/a | -US$19m |
| Jun 30 2022 | n/a | n/a | -US$52m |
| Mar 31 2022 | n/a | n/a | -US$450m |
| Dec 31 2021 | US$16m | US$1m | -US$330m |
| Sep 30 2021 | n/a | n/a | -US$161m |
| Jun 30 2021 | n/a | n/a | US$40m |
| Mar 31 2021 | n/a | n/a | US$518m |
| Dec 31 2020 | US$13m | US$1m | US$239m |
| Sep 30 2020 | n/a | n/a | US$179m |
| Jun 30 2020 | n/a | n/a | US$133m |
| Mar 31 2020 | n/a | n/a | US$280m |
| Dec 31 2019 | US$15m | US$1m | US$523m |
| Sep 30 2019 | n/a | n/a | US$609m |
| Jun 30 2019 | n/a | n/a | US$656m |
| Mar 31 2019 | n/a | n/a | US$486m |
| Dec 31 2018 | US$11m | US$979k | US$447m |
| Sep 30 2018 | n/a | n/a | US$520m |
| Jun 30 2018 | n/a | n/a | US$434m |
| Mar 31 2018 | n/a | n/a | US$447m |
| Dec 31 2017 | US$10m | US$950k | US$488m |
Compensazione vs Mercato: La retribuzione totale di Bruce ($USD 15.34M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 8.06M ).
Compensazione vs guadagni: La retribuzione di Bruce è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Bruce Cozadd (60 yo)
21.8yrs
Mandato
US$15,341,235
Compensazione
Mr. Bruce C. Cozadd serves as an Independent Director of Acelyrin, Inc. since March 7, 2022 and also serves as its Chairman of Board since January 2023. He served as Member of Board of Advisors at Cellares...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder | 21.8yrs | US$15.34m | 0.51% $ 34.8m | |
| President & COO | 1.1yrs | US$5.43m | 0.027% $ 1.8m | |
| Senior VP & Chief Accounting Officer | 5.3yrs | US$1.40m | Nessun dato | |
| Executive VP & Chief Legal Officer | 5.3yrs | US$3.88m | 0.018% $ 1.2m | |
| Executive VP | 5.5yrs | US$4.98m | 0.046% $ 3.1m | |
| Executive VP & CFO | less than a year | Nessun dato | 0.019% $ 1.3m | |
| VP & Head of Investor Relations | no data | Nessun dato | Nessun dato | |
| Executive VP & Chief People Officer | 6yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Sleep & CNS Medicine | no data | Nessun dato | Nessun dato | |
| Executive VP & Chief Commercial OfficerChief Commercial Officer | 4.7yrs | Nessun dato | 0.010% $ 704.6k | |
| Senior Vice President of Corporate Strategy | 5.2yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Technical Operations | 1.3yrs | Nessun dato | 0.0021% $ 140.7k |
5.2yrs
Durata media
53yo
Età media
Gestione esperta: Il team dirigenziale di JAZZ è esperto e expertise (durata media dell'incarico 5.2 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder | 21.8yrs | US$15.34m | 0.51% $ 34.8m | |
| Independent Director | 20.8yrs | US$513.77k | 0.045% $ 3.0m | |
| Independent Director | 12.8yrs | US$531.27k | 1.89% $ 128.7m | |
| Independent Director | 11.5yrs | US$533.77k | 0.020% $ 1.3m | |
| Independent Director | 15.3yrs | US$526.27k | 0.034% $ 2.3m | |
| Independent Director | less than a year | Nessun dato | Nessun dato | |
| Lead Independent Director | 14.5yrs | US$571.27k | 0.015% $ 985.9k | |
| Independent Non-Executive Director | 3.9yrs | US$533.77k | 0.0088% $ 594.5k | |
| Independent Director | less than a year | Nessun dato | 0.0024% $ 165.1k | |
| Independent Director | 11.5yrs | US$543.77k | 0.025% $ 1.7m | |
| Independent Non-Executive Director | 3.9yrs | US$521.27k | 0.0088% $ 594.5k | |
| Independent Director | 5.8yrs | US$523.77k | 0.018% $ 1.2m |
11.5yrs
Durata media
61.5yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di JAZZ è composto da personale esperto e esperto (durata media dell'incarico 11.5 anni).